Centene loses appeal over $65B defense health contract it lost


The U.S. Department of Defense has rejected Centene Corp.’s appeal of a decision to award a $65.1 billion contract to a group of Blue Cross Blue Shield plans.

Previous Renaissance Place apartment tower advances, may shed a floor of parking
Next Bothell biotech Curevo Vaccine names new chief medical officer